BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lai JC, Tandon P, Bernal W, Tapper EB, Ekong U, Dasarathy S, Carey EJ. Malnutrition, Frailty, and Sarcopenia in Patients With Cirrhosis: 2021 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology 2021;74:1611-44. [PMID: 34233031 DOI: 10.1002/hep.32049] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 39.0] [Reference Citation Analysis]
Number Citing Articles
1 Johnston HE, Takefala TG, Kelly JT, Keating SE, Coombes JS, Macdonald GA, Hickman IJ, Mayr HL. The Effect of Diet and Exercise Interventions on Body Composition in Liver Cirrhosis: A Systematic Review. Nutrients 2022;14:3365. [DOI: 10.3390/nu14163365] [Reference Citation Analysis]
2 Seshadri A, Appelbaum R, Carmichael SP, Cuschieri J, Hoth J, Kaups KL, Kodadek L, Kutcher ME, Pathak A, Rappold J, Rudnick SR, Michetti CP. Management of Decompensated Cirrhosis in the Surgical ICU: an American Association for the Surgery of Trauma Critical Care Committee Clinical Consensus Document. Trauma Surg Acute Care Open 2022;7:e000936. [DOI: 10.1136/tsaco-2022-000936] [Reference Citation Analysis]
3 Philips CA, Kedarisetty CK. Palliative Care For Patients With End-Stage Liver Disease. Journal of Clinical and Experimental Hepatology 2022. [DOI: 10.1016/j.jceh.2022.08.003] [Reference Citation Analysis]
4 Guo G, Li C, Hui Y, Mao L, Sun M, Li Y, Yang W, Wang X, Yu Z, Fan X, Jiang K, Sun C. Sarcopenia and frailty combined increases the risk of mortality in patients with decompensated cirrhosis. Ther Adv Chronic Dis 2022;13:20406223221109651. [PMID: 35875834 DOI: 10.1177/20406223221109651] [Reference Citation Analysis]
5 van Dijk AM, Coppens BJP, van Beers MA, Bruins Slot AS, Verstraete CJR, de Bruijne J, Vleggaar FP, van Erpecum KJ. Nutritional status in patients with hepatocellular carcinoma: Potential relevance for clinical outcome. Eur J Intern Med 2022:S0953-6205(22)00250-3. [PMID: 35902333 DOI: 10.1016/j.ejim.2022.07.002] [Reference Citation Analysis]
6 Nagel M, Labenz C, Dobbermann H, Czauderna C, Wallscheid NC, Schattenberg JM, Wörns MA, Galle PR, Marquardt JU. Suppressed serological vitamin A in patients with liver cirrhosis is associated with impaired liver function and clinical detoriation. Eur J Gastroenterol Hepatol 2022. [PMID: 35895982 DOI: 10.1097/MEG.0000000000002418] [Reference Citation Analysis]
7 Saleh ZM, Salim NE, Nikirk S, Serper M, Tapper EB. The emotional burden of caregiving for patients with cirrhosis. Hepatology Communications. [DOI: 10.1002/hep4.2030] [Reference Citation Analysis]
8 Nobbe AM, Mccurdy HM. Management of the Adult Patient with Cirrhosis Complicated by Ascites. Critical Care Nursing Clinics of North America 2022. [DOI: 10.1016/j.cnc.2022.04.005] [Reference Citation Analysis]
9 Hey P, Hoermann R, Gow P, Hanrahan TP, Testro AG, Apostolov R, Sinclair M. Reduced upper limb lean mass on dual energy X-ray absorptiometry predicts adverse outcomes in male liver transplant recipients. World J Transplant 2022; 12(6): 120-130 [DOI: 10.5500/wjt.v12.i6.120] [Reference Citation Analysis]
10 European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu., European Association for the Study of the Liver. EASL Clinical Practice Guidelines on management of Cystic Liver Diseases. J Hepatol 2022:S0168-8278(22)00347-6. [PMID: 35728731 DOI: 10.1016/j.jhep.2022.06.002] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Carey EJ. Survival of the less-fit. Hepatology 2022;75:1368-9. [PMID: 34953148 DOI: 10.1002/hep.32300] [Reference Citation Analysis]
12 Hui Y, Cui B, Wang X, Sun M, Li Y, Yang W, Guo G, Mao L, Yu Z, Fan X, Sun C. Sarcopenic obesity in liver disease: Handling both sides of the penny. Portal Hypertension & Cirrhosis 2022;1:42-56. [DOI: 10.1002/poh2.10] [Reference Citation Analysis]
13 European Association for the Study of the Liver. Electronic address: jhepatology@easloffice.eu., European Association for the Study of the Liver. EASL Clinical Practice Guidelines on Sclerosing Cholangitis. J Hepatol 2022:S0168-8278(22)00326-9. [PMID: 35738507 DOI: 10.1016/j.jhep.2022.05.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Soriano-Moreno DR, Dolores-Maldonado G, Benites-Bullón A, Ccami-Bernal F, Fernandez-Guzman D, Esparza-Varas AL, Caira-Chuquineyra B, Taype-Rondan A. Recommendations for nutritional assessment across clinical practice guidelines: A scoping review. Clin Nutr ESPEN 2022;49:201-7. [PMID: 35623814 DOI: 10.1016/j.clnesp.2022.04.023] [Reference Citation Analysis]
15 Ge J, Kim WR, Lai JC, Kwong AJ. "Beyond MELD" - Emerging strategies and technologies for improving mortality prediction, organ allocation and outcomes in liver transplantation. J Hepatol 2022;76:1318-29. [PMID: 35589253 DOI: 10.1016/j.jhep.2022.03.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
16 [DOI: 10.7759/cureus.24676] [Reference Citation Analysis]
17 Shah ND, Barritt AS. Nutrition as Therapy in Liver Disease. Clinical Therapeutics 2022. [DOI: 10.1016/j.clinthera.2022.04.012] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Kaps L, Lukac L, Michel M, Kremer WM, Hilscher M, Gairing SJ, Galle PR, Schattenberg JM, Wörns M, Nagel M, Labenz C. Liver Frailty Index for Prediction of Short-Term Rehospitalization in Patients with Liver Cirrhosis. Diagnostics 2022;12:1069. [DOI: 10.3390/diagnostics12051069] [Reference Citation Analysis]
19 Li C, Zhao C, Yu Z, Yang W, Sun M, Li Y, Guo G, Hui Y, Wang X, Fan X, Wang B, Zhang J, Sun C. Low free triiodothyronine levels are associated with frail phenotype in hospitalized inpatients with cirrhosis. Postgrad Med 2022. [PMID: 35382681 DOI: 10.1080/00325481.2022.2063487] [Reference Citation Analysis]
20 Topan M, Sporea I, Dănilă M, Popescu A, Ghiuchici A, Lupușoru R, Șirli R. Comparison of Different Nutritional Assessment Tools in Detecting Malnutrition and Sarcopenia among Cirrhotic Patients. Diagnostics 2022;12:893. [DOI: 10.3390/diagnostics12040893] [Reference Citation Analysis]
21 Wang S, Whitlock R, Lai JC, Taneja S, Tandon P. Reply. Hepatology 2022;75:1068-9. [PMID: 35006612 DOI: 10.1002/hep.32325] [Reference Citation Analysis]
22 Tantai X, Yeo YH, Wang J, Ji F. Reply to: “Evaluating sarcopenia in cirrhosis patients: the role of muscle function”. Journal of Hepatology 2022. [DOI: 10.1016/j.jhep.2022.04.023] [Reference Citation Analysis]
23 Ha NB, Lai JC. The bidirectional relationship between nonalcoholic fatty liver disease and sarcopenia. Hepatol Int. [DOI: 10.1007/s12072-022-10333-8] [Reference Citation Analysis]
24 Murakami N, Baggett ND, Schwarze ML, Ladin K, Courtwright AM, Goldberg HJ, Nolley EP, Jain N, Landzberg M, Wentlandt K, Lai JC, Shinall MC, Ufere NN, Jones CA, Lakin JR. Top Ten Tips Palliative Care Clinicians Should Know About Solid Organ Transplantation. J Palliat Med 2022. [PMID: 35275707 DOI: 10.1089/jpm.2022.0013] [Reference Citation Analysis]
25 Tapper EB, Zhao Z, Mazumder N, Parikh ND. Incidence of, Risk Factors for, and Outcomes After Ascites in a Population-Based Cohort of Older Americans. Dig Dis Sci 2022. [PMID: 35262903 DOI: 10.1007/s10620-022-07454-3] [Reference Citation Analysis]
26 Tantai X, Yeo YH, Wang J, Ji F. Reply to: “Gut liver muscle brain axis: a comprehensive viewpoint on prognosis in cirrhosis”. Journal of Hepatology 2022. [DOI: 10.1016/j.jhep.2022.03.013] [Reference Citation Analysis]
27 Iacob S, Mina V, Mandea M, Iacob R, Vadan R, Boar V, Ionescu G, Buzescu D, Gheorghe C, Gheorghe L. Assessment of Sarcopenia Related Quality of Life Using SarQoL® Questionnaire in Patients With Liver Cirrhosis. Front Nutr 2022;9:774044. [DOI: 10.3389/fnut.2022.774044] [Reference Citation Analysis]
28 Ayares G, Idalsoaga F, Díaz LA, Arnold J, Arab JP. Current Medical Treatment for Alcohol-Associated Liver Disease. Journal of Clinical and Experimental Hepatology 2022. [DOI: 10.1016/j.jceh.2022.02.001] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Bajaj JS, O'Leary JG, Lai JC, Wong F, Long MD, Wong RJ, Kamath PS. Acute-on-Chronic Liver Failure Clinical Guidelines. Am J Gastroenterol 2022;117:225-52. [PMID: 35006099 DOI: 10.14309/ajg.0000000000001595] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 6.0] [Reference Citation Analysis]
30 Tapper EB, Kenney B, Nikirk S, Levine DA, Waljee AK. Animal Naming Test Is Associated With Poor Patient-Reported Outcomes and Frailty in People With and Without Cirrhosis: A Prospective Cohort Study. Clin Transl Gastroenterol 2022. [PMID: 35080516 DOI: 10.14309/ctg.0000000000000447] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Chun HS, Lee M, Lee HA, Oh SY, Baek HJ, Moon JW, Kim YJ, Lee J, Kim H, Kim HY, Yoo K, Kim TH, Kim SU. Association of physical activity with risk of liver fibrosis, sarcopenia, and cardiovascular disease in NAFLD. Clin Gastroenterol Hepatol 2022:S1542-3565(22)00001-5. [PMID: 34998993 DOI: 10.1016/j.cgh.2021.12.043] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Chang J, Höfer P, Böhling N, Lingohr P, Manekeller S, Kalff JC, Dohmen J, Kaczmarek DJ, Jansen C, Meyer C, Strassburg CP, Trebicka J, Praktiknjo M. Pre-operative TIPS may reduce post-operative ACLF occurrence. JHEP Reports 2022. [DOI: 10.1016/j.jhepr.2022.100442] [Reference Citation Analysis]
33 Limon-miro AT, Jackson CD, Eslamparast T, Yamanaka-okumura H, Plank LD, Henry CJ, Madden AM, Garcia Ferreira L, Kalaitzakis E, Prieto de Frías C, Knudsen AW, Gramlich L, Raman M, Alberda C, Belland D, Den Heyer V, Tandon P, Morgan MY. Predicted estimates of resting energy expenditure have limited clinical utility in patients with cirrhosis. Journal of Hepatology 2022. [DOI: 10.1016/j.jhep.2022.01.005] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Siddique SM, May FP. Race-Based Clinical Recommendations in Gastroenterology. Gastroenterology 2021:S0016-5085(21)04050-6. [PMID: 34890599 DOI: 10.1053/j.gastro.2021.12.234] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
35 Kong M, Geng N, Zhou Y, Lin N, Song W, Xu M, Li S, Piao Y, Han Z, Guo R, Yang C, Luo N, Wang Z, Jiang M, Wang L, Qiu W, Li J, Shi D, Li R, Cheung EC, Chen Y, Duan Z. Defining reference values for low skeletal muscle index at the L3 vertebra level based on computed tomography in healthy adults: A multicentre study. Clin Nutr 2021;41:396-404. [PMID: 34999334 DOI: 10.1016/j.clnu.2021.12.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
36 . Erratum. Hepatology 2021;74:3563. [PMID: 34762312 DOI: 10.1002/hep.32224] [Reference Citation Analysis]
37 Kim SE, Kim DJ. Sarcopenia as a prognostic indicator of liver cirrhosis. J Cachexia Sarcopenia Muscle 2021. [PMID: 34812591 DOI: 10.1002/jcsm.12869] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
38 Tantai X, Liu Y, Yeo YH, Praktiknjo M, Mauro E, Hamaguchi Y, Engelmann C, Zhang P, Jeong JY, van Vugt JLA, Xiao H, Deng H, Gao X, Ye Q, Zhang J, Yang L, Cai Y, Liu Y, Liu N, Li Z, Han T, Kaido T, Sohn JH, Strassburg C, Berg T, Trebicka J, Hsu YC, IJzermans JNM, Wang J, Su GL, Ji F, Nguyen MH. Effect of sarcopenia on survival in patients with cirrhosis: A systematic review and meta-analysis. J Hepatol 2021:S0168-8278(21)02174-7. [PMID: 34785325 DOI: 10.1016/j.jhep.2021.11.006] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 19.0] [Reference Citation Analysis]
39 Boster JM, Feldman AG, Mack CL, Sokol RJ, Sundaram SS. Malnutrition in Biliary Atresia: Assessment, Management, and Outcomes. Liver Transpl 2021. [PMID: 34669243 DOI: 10.1002/lt.26339] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
40 Rich NE, Phen S, Desai N, Mittal S, Yopp AC, Yang JD, Marrero JA, Iyengar P, Infante RE, Singal AG. Cachexia is Prevalent in Patients With Hepatocellular Carcinoma and Associated With Worse Prognosis. Clin Gastroenterol Hepatol 2021:S1542-3565(21)01036-3. [PMID: 34555519 DOI: 10.1016/j.cgh.2021.09.022] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Ayorinde T, Panayotova G, Sharma A, Lunsford KE. Clinical and biomarker assessment of frailty in liver transplantation. Curr Opin Organ Transplant 2021. [PMID: 34343156 DOI: 10.1097/MOT.0000000000000911] [Reference Citation Analysis]